Resources
Advocacy groups
The limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) community has made exceptional strides in spreading awareness of the unmet medical needs of people with LGMD2I/R9 and creating a network to connect them with physician experts in neuromuscular diseases. Our partnership and collaboration with patient advocacy groups are essential to helping us understand what’s meaningful to people affected by this condition. Connect with our patient advocacy team at [email protected]
There are many independent advocacy groups that provide resources and support for individuals with LGMD2I/R9. Some of these groups and resources are listed below. You or your loved one’s health care provider can help you identify resources or a group that best suit your needs.
CureLGMD2i Foundation
Founded in 2011, the CureLGMD2i Foundation is a nonprofit organization with a mission of providing advocacy, spreading awareness, and supporting scientific research and drug development for LGMD. To date, they have provided more than $1.1 million to scientific and community programs.
The Speak Foundation
Founded in 2008 as the first patient-led organization for muscular dystrophy, TSF offers education, peer support, and advocacy for the worldwide LGMD and rare NMD community. It publishes the LGMD News magazine and has hosted international conferences and programs that amplify patient voices and promote research progress.
LGMD2i Research Fund
This nonprofit organization is committed to accelerating the finding of a cure for LGMD2I/R9 by supporting the most promising research projects and coordinating and managing the scientific process. They actively fund research for charitable purposes, forge partnerships with foundations and clinicians, and support patients with diagnostic and clinical trial resources.
LGMD Externally Led Patient‑focused Drug Development (EL‑PFDD) Meeting
The EL-PFDD meeting was held on September 23, 2022, and brought together patients with 6 LGMD subtypes (2A, 2C–F, 2I/R9) to describe disease impact, treatment priorities, and decision factors. The meeting was organized by a coalition of LGMD nonprofits and is available to view online.
LGMD Awareness Foundation
This nonprofit advocacy organization is dedicated to raising worldwide awareness of LGMD. In collaboration with other LGMD groups, they focus on providing curated educational information and resources. By increasing awareness of and advocating for individuals living with LGMD, the foundation assists in advancing diagnosis, care, and treatment as well as coordinates LGMD Awareness Day, which is celebrated worldwide on September 30 each year.
Hear from people with LGMD2I/R9
Listen to On Rare, a BridgeBio podcast where we talk to patients and
caregivers of a rare disease to learn more.
On Rare, Episode 17: “Improvise. Adapt. Overcome.” Dan is living with LGMD2I/R9
A podcast where Dan joins David Rintell, Head of Patient Advocacy at BridgeBio, to share the story of his long diagnostic odyssey and how a cancer scare ultimately led to his LGMD2I/R9 diagnosis. Dan shares his relief at receiving a diagnosis, paired with the fear of facing the unknown of a progressive neuromuscular disease.
Listen nowOn Rare, Episode 14: “Love isn’t love till it’s given away.” Determination has helped Lacey fulfill her dreams but hasn’t stopped the progression of LGMD2I/R9
A podcast where Lacey joins David Rintell, Head of Patient Advocacy at BridgeBio, to talk about how LGMD2I/R9 has impacted her life.
Listen nowOn Rare, Episode 1: “Something was not right with my muscles.” LGMD2I/R9 and the physical struggle to do basic life activities
A podcast with John and Tony, who have LGMD2I/R9. During their joint podcast interview, they tell us about their challenging diagnostic journeys and how their condition has changed the trajectory of their lives and forced them to navigate the world in ways that are often isolating.
Listen nowImpact of LGMD2I/R9
A busy wife, mother, attorney, and dog lover, Cyndy has been living with LGMD2I/R9 for more than 25 years. In her mid‑twenties, she began experiencing difficulties walking up stairs. Still, despite many tests, muscle biopsies, and interactions with doctors, it was more than 2 decades before she had a definitive diagnosis. “For 25 years, I lived without a diagnosis. I was having more and more difficulty climbing steps, more difficulty walking distances. [I] started to use a cane and then used a mobility scooter for distances. Most of the time, I was physically fatigued, but I was determined to live a full life and focused on my work.”
Of her own volition, she purchased a genetic test kit, and the results indicated she was a carrier for LGMD2I/R9. This testing led her to a more thorough and extensive genetic test and, ultimately, a definitive diagnosis. “There was definitely a sense of relief in thinking, ‘Okay, now that I have it, I know what I can do to manage it.’ But the downside is that some of the things that can result from this disease are terrifying and can be deadly. And just sort of seeing how my disease has progressed over the years, it made me very scared of what was to come. Thinking about, ‘Am I going to be able to manage my family? How are they going to handle it?’ It opened up a lot of questions.”
She encourages everyone living with LGMD2I/R9 to seek support from others who are on their own personal journeys and to become advocates for themselves and others living with the condition. “Learn as much as you can, do research on your own, and assemble your own team of health care professionals who are knowledgeable and experienced in limb‑girdle disease.”
When Seamus was about 8 years old, he and his family noticed he was having trouble walking. He also experienced extreme fatigue and pain, which prevented him from bike riding, swimming, hiking, and running as energetically as his siblings and from focusing during school. He didn’t know what was causing the problems. “I just knew that I hurt when I moved.”
Getting a diagnosis was not straightforward, but after ruling out potential tropical illnesses and other diseases that could have caused his symptoms, he was ultimately diagnosed with LGMD2I/R9.
“I was confused at first and sad. I didn’t know anything about it.” Seamus’s mom, Annie, was very scared in the beginning. “I was terrified he would just wake up one day and not be able to move.”
At school in Johannesburg, sports were an especially important activity, and being unable to join in was hard on him. He also found that teachers and classmates were often not sympathetic. He described one particularly cruel classmate and some teachers who berated him, asking why he could walk in the early part of the day but had to use a mobility device later in the day. He liked drama and thought that participating in the school play would be something he could excel in and enjoy, but he was unexpectedly cut from the cast. Having so few opportunities for extracurricular activities was hard, and he was very discouraged.
When asked what advice Seamus might give to another child newly diagnosed with LGMD2I/R9, he said, “Know what your own power is—your capabilities and limitations. Expect other people to be confused and not always understanding. Also, find things you like even though they may not be everything you want to do.” Annie added, “Turn fear into problem‑solving and think about what changes you can make to adapt along the way. Try to not get too caught up in what you can’t do and keep everything in perspective.”
Stay in the know